A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centered on text messages she exchanged with Pfizer ...

Physician's Choice, a U.S. maker of supplements and probiotics, is exploring a sale that could value the company at over $500 million, according to sources familiar with the matter.

Sanofi (SNYNF, SNY) said the EU has approved Sarclisa in combination with a standard-of-care regimen, bortezomib, lenalidomide, and ...

The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...

A new FDA warning letter for French pharmaceutical company Sanofi cited a handful of issues at its biologics factory in ...

After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...

Bank of America’s global fund manager survey revealed that respondents still believe U.S. equities will be the best for ...

Sanofi’s (NASDAQ:SNY) consumer healthcare unit Opella announced Tuesday that the U.S. FDA has lifted a clinical hold on a ...

Food companies criticize the science supporting front-of-package labeling, delay public consultation periods, push for their ...

"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.

Sanofi's Consumer Healthcare division, Opella, announced that the U.S. Food and Drug Administration has lifted a clinical hold on its ...

Focus on Digital Justice The theme of this year’s celebration highlights the importance of digital solutions for consumer justice. Three technical sessions will be held to discuss topics such as ...